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Background: Nasal secretion (NS) was investigated as a source of information regarding the mucosal and systemic
immune status of cattle challenged by respiratory disease. A method for the collection of substantial volumes
(~12 ml) of NS from cattle was developed to establish a reference range of analytes that are present in the NS of
healthy cattle. Biochemical profiles of NS from a group of 38 healthy Holstein-Friesian cows revealed high alkaline
phosphatase (AP) activity of up to 2392 IU/L. The character and source of the high activity of AP in bovine NS was
investigated.
Results: Histochemical analysis confirmed the localization of the AP enzyme activity to epithelial cells and serous
glands of the nasal respiratory mucosa. Analysis of mRNA levels from nasal mucosa by end point RT-PCR and PCR
product sequencing confirmed that the AP was locally produced and is identical at the nucleotide level to the
non-specific AP splice variant found in bovine liver, bone and kidney. Analysis by isoelectric focussing confirmed
that AP was produced locally at a high level in nasal epithelium demonstrating that AP from nasal secretion and
nasal mucosa had similar pI bands, though differing from those of the liver, kidney, bone and intestine, suggesting
different post-translational modification (PTM) of AP in these tissues.
Conclusions: A nasal isozyme of AP has been identified that is present at a high activity in NS, resulting from local
production and showing distinctive PTM and may be active in NS as an anti-endotoxin mediator.
Keywords: Bovine, Nasal secretion, Alkaline phosphatase, Isoelectric focusing, RT-PCRBackground
Bovine respiratory disease (BRD) is an important econo-
mic challenge to beef production globally and is estima-
ted to cost the UK cattle industry £60 million annually
[1]. We wished to investigate bovine nasal secretion
(NS) as a source of information regarding the mucosal
and systemic immune status of cattle in health and in re-
lation to BRD.
To use a body fluid such as NS for detection and moni-
toring of disease it was necessary to establish a reference
range of analytes that are present in the NS of healthy cat-
tle. However, for bovine NS there is no information on the
composition of the secretion, possibly due to the perceived
difficulty of collecting a sufficient volume of NS for ana-
lysis. A method was therefore developed which allowed* Correspondence: david.eckersall@glasgow.ac.uk
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unless otherwise stated.collection of over 10 ml of NS, sufficient for multiple in-
vestigations. Thereafter in the course of biochemical
analysis of NS, using a panel of tests that are used in
veterinary clinical biochemistry analysis, it was found
that the activity of the enzyme, alkaline phosphatase
(AP; EC 3.1.3.1) in the NS was markedly higher (up to
2392 IU/L) than the activity found in healthy bovine
serum (20–80 IU/L).
In cattle, as in other animals, AP exists as several iso-
zymes in different tissues, encoded by two known genes:
one for the intestinal form (IAP) and the other for the
non-specific AP which occurs in bone (BAP), liver (LAP)
and placenta (PLAAP) [2-4]. A major biochemical func-
tion of the enzyme family is to dephosphorylate molecules
with consequent change in function of those molecules.
Recent investigation into the function of AP has revealed
actions that could be relevant to its presence in NS. One
of these is the dephosphorylation of bacterial lipopolysac-
charides (LPS) resulting in detoxification of the LPS [5-8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Schematic representation of a collecting tube for
nasal secretion. The saturated tampon from nostril was inserted
into a modified collecting tube consisted of a 30 ml universal tube
with four × 2 mm holes drilled into the bottom, inserted in a 50 ml
Falcon tube.
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tenance of gut homeostasis, favouring the proliferation of
commensal bacteria over pathogens such as Salmonella
typhimurium [9]. This activity is proposed to be related to
local immunomodulating effects, likely via regulation of
the LPS-toll-like receptor 4 (TLR4) interactions between
gut microflora and intestinal epithelium [10].
Within the respiratory tract, AP activity has been pre-
viously demonstrated within the cell and on the surface
of respiratory epithelium in humans, where it is able to
dephosphorylate ATP to AMP and to adenosine, import-
ant for mucociliary clearance [11]. The enzyme was also
reported several decades ago in human nasal mucosa
[12] and more recently described in this tissue and,
though in micro litre volumes, of NS of guinea pigs [13].
Alkaline phosphatase activity has also been found in the
olfactory epithelium of mice and rats [14]. Apart from
these reports, the activity and production of AP in NS
and nasal mucosa has not, to our knowledge, been docu-
mented. The ability to collect substantial (ml) volumes
of bovine NS has enabled a biochemical analysis of the
NS and investigation of the possibility that the high ac-
tivity of AP in NS has a significant biological function.
The AP in NS could originate from either local syn-
thesis or secretion from cells in the bovine nasal epithe-
lium or it could be a result of leakage from serum.
However the latter theory is not supported by the find-
ing of higher activity of AP in NS than in serum unless a
mechanism to export the AP against a concentration
gradient is present in this tissue. The objective of this in-
vestigation was to characterise and identify the source of
the AP in bovine NS and establish if this AP has similar-
ity to established isoforms of the enzyme.
Methods
Animals and collection of nasal secretion
38 Holstein-Friesian cows aged 2–5 years were sampled
from a herd of 90 lactating cows from University of
Glasgow Cochno Farm. The animal experiments were car-
ried out with the approval of the University of Glasgow
MVLS College Ethics Committee and complied fully with
the Home Office of Great Britain and Northern Ireland
“Animals (Scientific Procedures) Act 1986”. Clinical exam-
ination was performed to ensure the cows were clinically
healthy and free from respiratory disease. The cows were
restrained in a cattle crush during the procedure. A com-
mercially available tampon was inserted into one nostril
and slid gently in an upwards and backwards direction
about 5–8 cm deep and then left in place for up to 15 mi-
nutes [15]. The tampon was then removed from the nos-
tril by gently pulling on the attached string and weighed,
as a measure of the NS uptake before being inserted into a
modified collecting tube (Figure 1). The cows were ob-
served during collection to ensure that there were no signsof discomfort but no signs of discomfort were observed at
any time in any cow in the study. The modified tubes were
centrifuged at 700 g for 10 minutes at 4°C in a procedure
similar to that of Lu and Esch [16]. Nasal secretion col-
lected at the bottom of Falcon tube was transferred into
1.5 ml tubes and stored at −80°C until further analysis.
Protein extraction for biochemical and immunological
analysis
Nasal mucosa, small intestine, heart, liver and kidney
samples from 6 adult cattle were collected at a slaughter-
house and processed within 24–48 hours. Nasal mucosa
was gently cut and separated from the nasal conchae using
a forceps and blade. Intestinal mucosa was obtained by
gently scraping the mucosa of the small intestine with a
metal spatula. Tissues were snap-frozen in liquid nitrogen
and stored at −80°C prior to extraction. Two grams from
each tissue were washed with isotonic saline solution and
homogenized (Janke & Kunkel Ultra Turrax T25) in 5 ml
saline. AP was extracted from 2 samples of crushed
cancellous bone obtained from the metacarpal bone of
2 cattle.
Tissue AP extracts were further processed by incuba-
tion with 100% n-butanol in ratio of 1:4 of n-butanol:
protein homogenates, with gentle agitation at 4°C for
30 minutes [17]. Extraction with n-butanol facilitates the
release of AP from membranes where it is anchored to
phosphatidylinositol [18]. The samples were centrifuged
at 1,500 g for 30 minutes at 4°C, the aqueous layer re-
moved and centrifuged at 15,000 g for 90 minutes with






ALPI NM_173987 ALPI-F GGGAGTGGTGACCACCTCCA
ALPI-R GTCAATGCGGCCTCCCTCCA
ALPL NM_176858 ALPL-F GACAGCTGCCCGCATCCTCA
ALPL-R CCTTCTCATCCAGCTCATACTCCA
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and the protein concentration in the AP extracts were
determined as described below. The AP activity of tissue
extracts was recorded as enzyme activity per gram of tis-
sue extracted (U/g). The relative AP activity in the dif-
ferent extracts was compared by a Kruskal-Wallis test
(GraphPad Prism 5.0, California, USA) with a signifi-
cance level (α) set at 0.05.
Biochemical and immunological analysis
The nasal secretions and tissue extracts were examined
for biochemical composition using an Olympus A640
analyser operated by Veterinary Diagnostic Services,
University of Glasgow. Enzymatic test were carried out
at 37°C where measurement of AP were based on the
recommendations of the German Society for Clinical
Chemistry (GSCC) at a pH of 10.4. Analysis method of
γ − glutamyl transferase (GGT) and aspartate transami-
nase (AST) were based on the recommendation of the
International Federation of Clinical Chemistry (IFCC).
Albumin was measured by a bromcresol green (BCG)
binding assay, total protein by reaction with biuret, urea
by reaction with 2-oxogluturate and nicotinamide aden-
ine dinucleotide (NADH), creatinine by reaction with
picric acid, total bilirubin by reaction with 3,5-dichloro-
phenyldiazonium tetrafluoroborate (DPD), calcium by
reaction with o-Cresolphthalein-complexone (oCPC) and
phosphate by reaction with molybdate. Measurements of
electrolytes were carried out by ion-specific electrodes
using an indirect potentiometry method. Measurement of
bovine IgA and IgG concentrations using species-specific
ELISAs (Bethyl Labs, Texas, USA) according to the manu-
facturer’s instructions.
Histochemical analysis
Bovine nasal mucosa were collected for histology exam-
ination as described above with a 1 cm square dissected
out and snap frozen in liquid nitrogen. Cryosections of
8 μm were fixed with acetone, stained with Vector®
Red Alkaline Phosphatase Substrate Kit (Vector Labs,
Peterborough, UK), in the presence or absence of lev-
amisole inhibitor (Sigma-Chem Co, Poole, UK) coun-
terstained with Gills Haematoxylin (Sigma-Chem Co,
Poole, UK) and mounted with Histomount (National
Diagnostics, New Jersey, USA). Images were taken with
Olympus BX51 and attached DP71 camera (Olympus,
Japan), using Cell^D software (Olympus, Japan).
Total cellular RNA extraction
Tissue samples of 100 mg from the same cattle used
for the preparation of tissue extracts were used for
RNA preparation using PureZOL™ (Bio-Rad Laboratories,
Hemel Hempstead, UK) according to the manufacturer’s
protocol.End point reverse transcriptase – polymerase chain
reaction (RT-PCR)
Reverse transcription (RT) reactions were performed on
RNA samples from nasal mucosa, liver and small in-
testine. 2 μg RNA samples were denatured at 65°C for
5 minutes. 50 μl reactions comprising 2 μg of total RNA
sample, 1 × First strand buffer, 0.5 mM each of dNTPs,
10 mM dithiothreitol, 3 μg random primers, 20 U of
RNAseOut and 400 U M-MVL reverse transcriptase
(Life Technologies Ltd, Paisley, UK) were incubated for
30 minutes at 37°C, 60 minutes at 42°C, 15 minutes at
70°C and quenched at 4°C. The PCR products were ana-
lysed on 2% (w/v) agarose gels containing ethidium bro-
mide (0.5 μg/ml).
Primers were designed to amplify specific regions of
the bovine intestinal AP (IAP) gene ALPI (NM_173987)
and non-specific AP gene ALPL (NM_176858), respect-
ively using an interactive web-based primer program al-
gorithm, GeneFisher software version 1.2.2 (BiBiServe,
Bielefeld, Germany), with a predicted size PCR product
of 500 bp. The primer sequences are depicted in Table 1.
A total volume of 25 μl PCR reaction was prepared, com-
prising 12.5 μl RedTaq® DNA polymerase buffer (Sigma
Chem. Co, Poole, UK), 0.5 μl of each primer (5 pmol per
reaction tube), and 200 ng gDNA. Amplification condi-
tions were 30 cycles (94°C for five minutes, 94°C for one
minute, 58°C for one minute, 72°C for one minute, 72°C
for 10 minutes). The PCR products (2 μl) were visualised
using ethidium bromide (0.5 μg/ml) stained agarose gel
and quantified against a 100 bp mass ladder for DNA (Life
Technologies, Paisley, UK).
Sequencing
PCR products from RT-PCR reactions were purified using
a QIAquick PCR purification kit (Qiagen, Crawley, UK)
according to the manufacturer’s instructions. The PCR
products were sequenced using Big Dye v3.1 Terminator
(Life Technologies, Paisley, UK) in 10 μl reaction volume
containing 200–500 ng template, 1X sequencing buffer,
32 mM primer and 1x Big Dye mix. The sequencing re-
actions were carried out in two random nasal mucosa
samples with forward and reverse primers in separate re-
actions. The sequencing products were ethanol precipi-
tated, resuspended in formamide and read using capillary
Table 2 Biochemical and immunological compositions of
bovine nasal secretion (n = 38)
Analytes (unit) Median (Range) Reference range
(Bovine serum)a
Urea (mmol/L) 3.1 (1.8 - 6.1) 0 - 8
Calcium (mmol/L) 1.1 (0.6 - 1.4) 2.2 - 3.3
Phosphate (mmol/L) 0.8 (0.4 - 1.6) 1.1 - 2.8
Creatinine (μmol/L) 30 (5 - 61) 53 - 132
Total bilirubin (μmol/L) 0 (0 - 2) 0 - 8
Total protein (g/L) 14 (9 - 34) 52 - 84
Albumin (g/L) 3 (0 - 5) 21 - 34
Sodium (mmol/L) 60 (18 - 98) 135 - 151
Potassium (mmol/L) 2.4 (0.6 - 3.9) 3.2 - 5.8
Chloride (mmol/L) 19 (14 - 34) 96 - 111
Alkaline phosphatase (IU/L) 1155 (144 - 2392) 20 - 80
Aspartate transaminase (IU/L) 97 (50 - 184) 10 - 140
Gamma-glutamyltransferase (IU/L) 68 (28 - 109) 0 - 27
IgA (g/L) 1.2 (0.5 - 2.0) 1.8 - 3.9b
IgG (g/L) 0.5 (0.2 - 1.9) 0.1 - 0.7c
aLaboratory reference range for bovine serum; bMorgan et al., [19]; cDuncan
et al., [20].
Table 3 AP activity in bovine tissue extracts (n = 6)
Tissue Median (IU/g) (Range)
Nasal mucosa 14.3 (1.0 - 27.6)
Intestinal mucosa 6.5 (2.2 - 24.0)
Heart 0.6 (0.2 - 1.1)*
Kidney 7.4 (3.9 - 16.2)
Liver 8.3 (1.0 - 27.2)
*AP activity was significantly different from all other tissue extracts (P < 0.05).
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Analyzer (Hitachi, Tokyo, Japan).
Isoelectric focusing (IEF)
The pI of the various AP isozymes was determined by
separation using Invitrogen Novex® pH 3–7 IEF Gel (Life
Technologies, Paisley, UK). Samples of bovine NS and
tissue extracts from NS, nasal mucosa, small intestine,
liver, kidney and bone were selected at random from the
available samples for the separation of AP isozymes.
Samples were diluted to an AP activity of 300–350 IU/L
in IEF sample buffer pH 3–7 (Life Technologies, Paisley,
UK) prepared according to manufacturer’s instructions.
Ten microliters of the prepared sample were loaded into
each well such that equal activities of AP were loaded
into each well. Isoelectric focussing was conducted at
4°C using the following voltage gradient: 100 V, 1 hour;
200 V, 1 hour; 500 V, 30 minutes. The gel was then
stained with Pierce 1-Step™ NBT-BCIP ALP substrate so-
lutions at pH 9.2 (Thermo Fisher Scientific Inc, Illinois,
USA) for 5 hours at 37°C. The pI of focussed bands was
estimated in comparison to pH 3–10 standards (Serva
Electrophoresis, Heidelberg, Germany) which were run
in a track of the IEF gels, with the track being excised
and stained separately with Coomassie blue following
isoelectric focusing.
Results
Biochemistry of bovine nasal secretion
A volume of between 5–12 ml of NS was collected from
each of 38 Holstein-Friesian dairy cows. Protein concen-
trations in nasal secretion ranged from 9 to 34 g/L. Fol-
lowing biochemical analysis the mean (±SD) AP activity
in NS was 1239 ± 553 IU/L and was up to 16-fold higher
than the serum reference range for AP (Table 2) while
GGT activity was 2.6-fold higher than the bovine serum
GGT reference range. Concentrations of total protein,
albumin, calcium, phosphate, sodium and chloride were
lower than the serum reference range while urea, cre-
atinine, bilirubin and aspartate transaminase levels were
comparable to serum reference ranges. The concentra-
tions of IgA and IgG were 0.5 - 2 g/L and 0.2 - 1.9 g/L
respectively.
Distribution and localisation of AP activity
The extracts from nasal mucosal tissue (n = 6) had mean
AP activities which were not significantly different from
the mean activity extracted from other bovine tissues
known to produce this enzyme: liver, intestine and kid-
ney. All of these extracts had significantly higher AP
activities per gram of wet tissue extracted compared
with the heart tissue (Table 3) that served as a negative
control.Histochemistry using an AP activity stain showed strong
AP activity (Figure 2) in the luminal and basal ends of
nasal epithelium (yellow arrow) and serous glands (green
arrow). AP activity staining was abolished in the presence
of levamisole a known non-specific AP inhibitor.
Analysis of nasal mucosa AP mRNA abundance levels
A single PCR product at the predicted size of 500 bp was
detected in the nasal mucosa using primers for bovine
non-specific AP gene ALPL (NM_176858) (Figure 3a) but
not with primers for the intestinal AP (IAP) gene ALPI
(NM_173987) (Figure 3b). Liver and intestine cDNAs
served as positive and negative controls for each primer
pair. Sequencing of PCR products from two biological
samples of nasal tissue showed homology to the ALPL
splice variant.
Isoelectric focusing of AP isoforms
The AP from various bovine tissues separated by IEF
and stained by zymography with an AP susbstrate, are
Figure 2 Histology and alkaline phosphatase activity histochemistry of nasal mucosa. Routine staining of nasal mucosa with Haematoxilin
and Eosin (left column) and histochemical staining of AP activity using Vector Red substrate (central column) showed strong AP activity in the
mucus at the luminal surface and in the basal cell layers of the epithelium (yellow arrow); as well as in serous glands (green arrow). Levamisole, a
non-specific AP inhibitor, abolished the histochemical staining of these cells (right column). Image captures at x10, x20 and x40 magnifications
are shown with appropriate scale bars.
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sults. The IEF demonstrated that AP from the NS (run
in duplicate) had isoforms forming bands of AP activity
with pI of 4.8 (Figure 4–1) and 5.0-5.3 (Figure 4–2).
There were inter-individual difference found in the AP
bands from NS samples at pI 5.0-5.3 illustrated by NS
samples (a) and (b) with sample (b) showing greater ac-
tivity and had a smeared appearance. The nasal mucosal
extract also had major bands with pI 4.8-5.2 (Figure 4–3)
and several minor bands with pI of 5.3 - 6.2 (Figure 4–4).
Bovine bone AP had an isoform with pI of 4.8 (Figure 4–5)
and 5.0-5.3 (Figure 4–6), with several bands with pI ofFigure 3 Alkaline phosphatase mRNA analysis from bovine tissues by
of genes for AP. The presence of a single 500 bp DNA fragment correspon
(a) non-specific AP primers and (b) intestinal AP primers. PCR products we
used. M =Marker (100 bp DNA ladder); MQ = high purity water; B = blank; N6.0 – 6.7 (Figure 4–7). The liver AP focussed with lower
pI showing a major band at pI 4.6 (Figure 4–8). Intes-
tinal and kidney AP had isoforms with pI of 5.4-6.2
(Figure 4–9) while kidney AP also having major bands
between with pI of 5.2 and 5.3 (Figure 4–10). The pI of
the isoforms were estimated by comparison to standard
protein of known pI value run on the same IEF gel with
the track of the standard proteins separated and visua-
lised with Coomassie blue protein stain rather than with
AP zymography. Although diluted to a similar AP activ-
ity, notable differences were observed in the band inten-
sity of the AP isoforms. Close inspection of the loadingRT-PCR. Bovine tissues examined by RT-PCR to determine expression
ding to the predicted product size was visualised when using
re present in nasal mucosa only when non-specific AP primers were
= nasal mucosa; L = liver; I = intestine.
Figure 4 Isoelectric focussing of alkaline phosphatase in bovine tissue and nasal secretion. Bovine tissue extracts and nasal secretion
separated on isoelectric focusing gels over a pH 3–7 range and stained with 5-Bromo-4-chloro-3-indolyl phosphate with nitro blue tetrazolium
chloride (BCIP/NBT) substrate. M = IEF standard protein marker (stained with Coomassie blue); −ve = cathode; +ve = anode. Two different samples
of NS were run in duplicate. Samples of extracts from nasal mucosa, bone and intestine were run in duplicate with liver and kidney extract being
run in single tracks. Annotated boxes around isoforms bands as discussed in the text.
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showed a deposit of AP activity, suggesting that a pro-
portion of the AP in these samples were unable to enter
the polyacrylamide gel, possibly due to the formation of
large aggregates.
Discussion
This investigation had the original objective to collect
and characterise bovine NS as a readily available bio-
logical fluid in the search for biomarkers of BRD. How-
ever prior to this, it was necessary to establish the
normal components of the fluid and their concentration
in NS from healthy cattle. Swabbing the nasal tract
proved to be an inefficient method of collection of the
fluid. A system was therefore developed which allowed
bovine NS to be collected in sufficient volume for ana-
lysis. Previous studies have collected NS on tampons
[15] but in this study the sample was removed from the
absorbent by centrifugation using modified centrifuge
and universal tubes, which allowed up to 12 ml of NS to
be collected from each animal.
Biochemical analysis showed that most analytes were
at similar or lower concentrations to those in bovine
serum. Unexpectedly, it was found that the activities of
AP and GGT were greater by factors of close to ten-fold
and three-fold respectively in the NS than in serum from
healthy animals. To our knowledge there are no previousreports of the activities of these enzymes in NS being
greater than that found in serum or plasma. Indeed in
the classic text on AP by McComb et al. [2] there is no
mention of AP in nasal mucosa or NS and only one ref-
erence to AP in olfactory cells related to the nasal cavity
[21]. The lack of prior reports on the activity of AP in
NS is likely to be due to the difficulty of collection of
sufficient volumes of this fluid from animals such as la-
boratory rodents and reluctance of human volunteers to
undertake NS collection. Whether the high activity of
GGT in NS is also produced locally is an open to ques-
tion and would require confirmation by gene expression
or by histochemical analysis.
Alkaline phosphatase is synthesised in several tissues
in mammals and distinct gene products have been iden-
tified in cattle with one form being produced in the in-
testine (IAP) and a second isoform, non-specific AP,
being synthesised in liver, kidney and bone [3,22]. Re-
cently, a study conducted by Yang et al. [4] discussed the
evolution of AP genes, indicating that mammals have
lost 1 of 3 clades present in zebrafish, however they also
indicated that IAP is regulated by Myd88 dependent in-
nate immune signalling with activity in reducing host re-
sponses to inflammatory microbiota products [4]. An
activity based AP specific histochemical stain was used
on sections of bovine nasal epithelia and indicated that
AP is present in the mucus layer and in secretory cells
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approach, the enzyme has been previously identified in
human nasal mucosa [12] in the nasal epithelium of
guinea pigs [13] and the olfactory epithelium of mice
and rats [14] but only limited volumes of NS were avail-
able for analysis. The study of AP in the nasal epithelium
of guinea pigs [13] did detect AP activity in NS collected
by lavage, but only a total volume of 30 μl of lavage fluid
was collected per guinea pig, which would not be a suffi-
cient volume for many investigations. Measuring AP ac-
tivity from nasal mucosa for comparison to extracts of
other bovine tissues revealed that the activity of AP per
gram of tissue from nasal mucosa was equivalent to that
of liver, kidney and intestine indicating that nasal mu-
cosa is a major site for AP synthesis and secretion.
Enzyme isoforms can be separated by electrophoretic
means to aid in identification of relative isoforms. Iso-
electric focusing was able to separate the AP and al-
lowed the enzyme activity to be detected by AP activity
staining. Although similar AP activity was loaded on to
the IEF gel, inspection revealed notable differences in
the band intensities. This difference was possibly due to
differences in the ability of the AP enzyme to penetrate
the polyacrylamide gel which was especially evident in
the NS samples (Figure 4–11). This could be due to the
formation of aggregates, possibly with high molecular
weight and complex proteoglycans contained in nasal
mucus remaining at the sample well. Smearing of IEF
track from NS sample (b) (Figure 4–2) and its greater
activity compared to sample (a) may be due to partial
degradation of AP molecules during sample preparation
which could allow greater penetration of the gel by
smaller AP forms. Staining was carried out at pH 9.2
and as there is a possibility that different AP isoform
would optimally stain at different pHs and this may also
contribute to the variation seen in AP activity on the
IEF gel. Nevertheless, the AP isoforms in NS had pIs in
the same region as those of the nasal mucosa extracts
(pH 4.2-6.8) but were clearly different from the extracts
of other tissues. The differences in IEF migration of the
AP extracts is likely to be due to post translational mod-
ifications (PTMs) such as glycosylation or phosphoryl-
ation, the elucidation of which would be the subject of
further investigation.
PCR using primers based on the published sequences
of bovine intestinal [4] and non-specific AP [3] estab-
lished that the nasal mucosa PCR product is identical to
the bovine non intestinal AP messenger and was not re-
lated to intestinal AP. This was further confirmed by se-
quencing the PCR product which showed complete
sequence identity with the published bovine non-specific
AP sequence [22].
Recent studies of the biological function of AP have re-
vealed that the enzyme has the ability to dephosphorylatelipopolysaccharide (LPS) endotoxin from Gram negative
bacteria [23-25] reducing the toxic effects of LPS [26]
and, in the intestine, can be induced by Resolvin E1, an
anti-inflammatory derivative of omega-3 fatty acids [27].
Thus intestinal AP has a major function in reducing the
effects of LPS from intestinal bacterial flora [5] and may
have a similar function in livestock [28]. If AP in NS has
the same activity on LPS then its presence in this secretion
could contribute to the host defences by acting against in-
vading pathogens in the respiratory tract responsible for
BRD. It is of interest that AP in bronchial and alveolar
fluid is believed to function in the extracellular dephos-
phorylation of ATP to fuel the activity of cilia in the air-
ways [11] while there may also be interaction between
ATP and nasal AP in minimizing inflammation as has
been suggested for IAP [8]. This may be relevant to its
presence in NS, while de-phosphorylation of the proin-
flammatory nucleotide uridine diphosphate (UDP), an ac-
tion of IAP [29] and the relative stability of UDP on the
airway surface of human [30] could provide nasal AP as a
potential anti-inflammatory action with therapeutic value
for the treatment of airway diseases. Furthermore in this
species, NS can be transferred to the mouth as cattle have
the tendency to lick their muzzle and nostrils so that the
nasal AP could be effective in the rumen as an anti-
endotoxin with a de-phosphorylation activity [8].Conclusion
This investigation has shown that AP is present in sub-
stantial activity in bovine NS. We have demonstrated
that AP activity found in bovine NS is produced locally
in the nasal epithelium and does not result from transfer
from the serum. This is based on the findings that AP
was extracted from nasal epithelium with a similar effi-
ciency as from liver, bone, kidney or intestinal tissue, AP
activity was detected by histochemistry in sections of the
nasal epithelium and the mRNA for bovine non-specific
AP was present in this tissue. Isoelectric focusing de-
monstrated differences between the AP of NS and ex-
tracts of AP from other tissues with differences likely to
be resulting from PTMs. The discovery of AP in nasal
epithelium and NS in cattle presents opportunities for
further investigation of the role of the enzyme in the
susceptibility of mammals to infection through the nasal
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